AbbVie Deutschland GmbH & Co. KG

Track this competitor Create a free account to be notified when it wins a contract.

Contracts won: 1
Amount won alone: €0 excl. VAT
Period: 16 July 2026 – 16 July 2026

Its main clients

AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen · 1 contract

Where and what

Supplies · 1

Its contracts coming to an end

So many opportunities to take over these contracts when they are re-tendered.

Planned end	Contract	Current holder	Amount
31 August 2028 re-tender around March 2028	Vereinbarung nach § 130c SGB V für das Arzneimittel Maviret mit der Wirkstoffkombination Glecaprevir/Pibrentasvir AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen framework agreement	AbbVie Deutschland GmbH & Co. KG 1 bid received	€0

Contracts won

Date	Contract	Buyer	Amount
16/07/2026	Vereinbarung nach § 130c SGB V für das Arzneimittel Maviret mit der Wirkstoffkombination Glecaprevir/Pibrentasvir	AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen	€0

Source: contract award notices published on TED (Publications Office of the European Union), above the EU thresholds. Contracts published only in Belgium are not included yet.